Sanguine Biosciences
Sherman Oaks, US · Founded 2010 · 1 known investors
Founders & leadership
TT
Tim TricheNamed on SEC filing
RH
Rudiger HausherrNamed on SEC filing
RS
Randy SocolNamed on SEC filing
BN
Brian NemanNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 round · 2014
▶$5.5MraisedNov 2014 · 74 investors · Other TechnologyRule 506(b)
▶$5.5MraisedNov 2014 · 74 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Tim TricheDirector
- Rudiger HausherrDirector
- Randy SocolExecutive Officer
- Brian NemanExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $5.5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Sanguine Biosciences's investors?
- Sanguine Biosciences's investors include Catalio Capital Management, LP.
- How much funding has Sanguine Biosciences raised?
- Sanguine Biosciences has disclosed $5.5M raised across 1 round.
- Where is Sanguine Biosciences headquartered?
- Sanguine Biosciences is headquartered in Sherman Oaks, US.